Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 51,500
0.00 (0.00%)
Apr 29, 2026, 9:10 AM KST
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.62 trillion as of April 28, 2026. Its market cap has increased by 92.94% in one year.
Market Cap
2.62T
Enterprise Value
2.62T
Revenue
155.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
51,500.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.62T, an increase of 9,844.04%. That is a compound annual growth rate of 16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.62T | 17.72% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 6.96T |
| Hanmi Pharm. | 6.27T |
| Celltrion Pharm | 2.56T |
| Daewoong Pharmaceutical | 1.72T |
| GC Biopharma | 1.62T |
| Chong Kun Dang Pharmaceutical | 1.16T |
| DongKook Pharmaceutical | 1.14T |
| Daewoong | 948.66B |